NovaBay Pharmaceuticals, Inc. Change in payables and accrued liability

Change in payables and accrued liability of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Change in payables and accrued liability growth rates and interactive chart.


Highlights and Quick Summary

  • Change in payables and accrued liability for the quarter ending June 30, 2022 was $-1.13 Million (a -195.77% decrease compared to previous quarter)
  • Year-over-year quarterly Change in payables and accrued liability decreased by -292.52%
  • Annual Change in payables and accrued liability for 2021 was $-163 Thousand (a -150.78% decrease from previous year)
  • Annual Change in payables and accrued liability for 2020 was $321 Thousand (a -117.83% decrease from previous year)
  • Annual Change in payables and accrued liability for 2019 was $-1.8 Million (a -448.84% decrease from previous year)
  • Twelve month Change in payables and accrued liability ending June 30, 2022 was $213 Thousand (a -71.68% decrease compared to previous quarter)
  • Twelve month trailing Change in payables and accrued liability decreased by -6.58% year-over-year
Trailing Change in payables and accrued liability for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$213 Thousand $752 Thousand $-163 Thousand $228 Thousand
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Change in payables and accrued liability of NovaBay Pharmaceuticals, Inc.

Most recent Change in payables and accrued liabilityof NBY including historical data for past 10 years.

Interactive Chart of Change in payables and accrued liability of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Change in payables and accrued liability for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-1.13 $1.18
2021 $-0.43 $0.59 $-0.59 $0.27 $-0.16
2020 $-0.03 $-0.12 $0.09 $0.38 $0.32
2019 $-0.29 $-0.14 $-0.89 $-0.52 $-1.8
2018 $0.54 $0.27 $-0.17 $-0.16 $0.52
2017 $-0.86 $0.21 $0.16 $0.23 $-0.26
2016 $-0.43 $-0.39 $-1.06 $-0.48 $-2.36
2015 $0.59 $1.34 $-0.64 $0.36 $1.64
2014 $0.86 $0.26 $-0.22 $-1.15 $-0.25
2013 $0.46 $0.56 $0.62 $-0.22 $1.41
2012 $-0.63 $0.5 $0.63 $0.17 $0.67
2011 $0.51 $-0.45 $0.35

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology